Factors Associated with Treatment Uptake Among Women with Acetic Acid/Lugol’s Iodine Positive Lesions of the Cervix in Cameroon

References

• Wright TC, Cox TJ. Cervical cancer: epidemiology and etiology. In: Mayeaux EJ, Cox JT, editors. Modern Colposcopy: Textbook and Atlas. 3rd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2014:61–73.
   Google Scholar
• Cox JT, Chelmow DP, Moscicki AB. Management of abnormal cervical cancer screening. In: Mayeaux EJ, Cox JT, editors. Modern Colposcopy: Textbook and Atlas. 3rd ed. Philadelphia PA; Wolters Kluwer/Lippincott Williams and Wilkins Health. 2014:571–598.
   Google Scholar
• World Health Organization (WHO). Comprehensive Cervical Cancer Control. December 2014. 2014;364. Available from: http://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/%5Cnwww.who.int. Accessed June 16, 2020.
   Google Scholar
• DeGregorio GA, Bradford LS, Manga S, et al. Prevalence, predictors, and same day treatment of positive VIA enhanced by digital cervicography and histopathology results in a cervical cancer prevention program in Cameroon. PLoS One. 2016;11(6):e0157319. doi:10.1371/journal.pone.0157319
   Web of Science ®Google Scholar
• Neuman B. The Neuman systems model. In: Neuman B, Fawcett J, editors. The Neuman Systems Model. 5th ed. Upper Saddle River, NJ: Pearson; 2011:3–33.
   Google Scholar
• Ezechi OC, Petterson KO, Gabajabiamila TA, et al. Predictors of default from follow-up care in a cervical cancer screening program using direct visual inspection in south-western Nigeria. BMC Health Serv Res. 2014;14(1). doi:10.1186/1472-6963-14-143
   Web of Science ®Google Scholar
• Reimers LL, Sotardi S, Daniel D, et al. Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women. Gynecol Oncol. 2010;119(1):92–97. doi:10.1016/j.ygyno.2010.06.012
   Web of Science ®Google Scholar
• Parham GP, Mwanahamuntu MH, Kapambwe S, et al. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015;10(4):e0122169. doi:10.1371/journal.pone.0122169
   PubMed Web of Science ®Google Scholar
• Manga S, Kanjo M, Ngwa W. Challenges with cervical cancer treatment in Cameroon. Obstetrics Gynaecol Cases Rev. 2017;4(2):1–5. doi:10.23937/2377-9004/1410104
   Google Scholar
• Manga S, Parham G, Nkoum B, et al. Cervical cancer screening in cameroon. J Low Genit Tract Dis. 2015;19(4):288–294. doi:10.1097/LGT.0000000000000133
   PubMed Web of Science ®Google Scholar
• Horo A, Jaquet A, Ekouevi D, et al. Cervical cancer screening by visual inspection in Cote d’Ivoire, operational and clinical aspects according to HIV status. BMC Public Health. 2012;12(1):237. doi:10.1186/1471-2458-12-237
   Web of Science ®Google Scholar
• Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, et al. Management of cryotherapy-ineligible women in a “screen-and-treat” cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008;110:402–407. doi:10.1016/j.ygyno.2008.04.031
   Web of Science ®Google Scholar
• Degregorio G, Manga S, Kiyang E, et al. Implementing a fee-for-service cervical cancer screening and treatment program in Cameroon: challenges and opportunities. Oncologist. 2017;22(7):850–859. doi:10.1634/theoncologist.2016-0383
   Web of Science ®Google Scholar
• Manga S, Kiyang E, Demarco RF. Barriers and facilitators of follow-up among women with precancerous lesions of the cervix in Cameroon: a qualitative pilot study. Int J Women’s Health. 2019;Volume 11:229–239. doi:10.2147/IJWH.S196112
   Web of Science ®Google Scholar
• Gaffikin L, Blumenthal PD, Emerson M, et al. Feasibility of a single visit approach to cervical cancer prevention: results from a demonstration project in rural Thailand. Lancet. 2003;361:814–820. doi:10.1016/s0140-6736(03)12707-9
   PubMed Web of Science ®Google Scholar
• Mark K, Frost A, Hussey H, et al. Rates of regression of cervical dysplasia between initial biopsy and excisional procedure in routine clinical practice. Arch Gynecol Obstet. 2019;299(3):841–846. doi:10.1007/s00404-018-5026-8
   Web of Science ®Google Scholar
• Lofgren SM, Tadros T, Herring-Bailey G, et al. Progression and regression of cervical Pap test lesions in an urban AIDS clinic in the combined antiretroviral therapy era: a longitudinal, retrospective study. AIDS Res Hum Retroviruses. 2015;31(5):508–513. doi:10.1089/aid.2014.0254
   PubMed Web of Science ®Google Scholar
• Martingano D, Renson A, Martingano AJ, et al. Variations in progression and regression of precancerous lesions of the uterine cervix on cytology testing among women of different races. J Am Osteopathic Assoc. 2018;8(1):8–18. doi:10.7556/jaoa.2018.003
   Web of Science ®Google Scholar
• Munro A, Spilsbury KA, Cohen P, et al. Spontaneous regression of CIN2 in women aged 18-24 years: a retrospective study of a state-wide population in Western Australia. Acta Obstet Gynecol Scand. 2015;95(3):291–298. doi:10.1111/aogs.12835
   Web of Science ®Google Scholar
• Moscicki AB, Ma Y, Wibbelsman C, et al. Rate of and risks for regression of CIN-2 in adolescents and young women. Obstet Gynecol. 2011;116(6):1373–1380. doi:10.1097/AOG.0b013e3181fe777f
   Web of Science ®Google Scholar
• Aerssens A, Claeys P, Garcia A, et al. Natural history and clearance of HPV after treatment of precancerous cervical lesions. Histopathology. 2008;52(3):381–386. doi:10.1111/j.1365-2559.2007.02956.x
   PubMed Web of Science ®Google Scholar
• Bae JH, Kim CJ, Park TC, et al. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer. 2007;17:1271–1277. doi:10.1111/j.1525-1438.2007.00945.x
   PubMed Web of Science ®Google Scholar
• Santeso N, Reem AM, Holger JS, et al. World Health Organization guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynecol Obstet. 2016;132(3):252–258. doi:10.1016/j.ijgo.2015.07.038
   Web of Science ®Google Scholar
• Cholli P, Bradford L, Manga S, et al. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: findings of initial screening and one-year follow-up. Gynecol Oncol. 2017. doi:10.1016/j.ygyno.2017.11.002
   Web of Science ®Google Scholar